These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18245138)

  • 21. Investigation of resting-state EEG functional connectivity in frontotemporal lobar degeneration.
    Pijnenburg YAL; Strijers RLM; Made YV; van der Flier WM; Scheltens P; Stam CJ
    Clin Neurophysiol; 2008 Aug; 119(8):1732-1738. PubMed ID: 18490193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B; Agosti C; Premi E; Cerini C; Cosseddu M; Paghera B; Bellelli G; Padovani A
    Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease.
    Alberici A; Geroldi C; Cotelli M; Adorni A; Calabria M; Rossi G; Borroni B; Padovani A; Zanetti O; Kertesz A
    Neurol Sci; 2007 Apr; 28(2):80-6. PubMed ID: 17464470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease.
    Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC
    J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls.
    Looi JC; Walterfang M; Styner M; Svensson L; Lindberg O; Ostberg P; Botes L; Orndahl E; Chua P; Kumar R; Velakoulis D; Wahlund LO
    Neuroimage; 2010 Jul; 51(3):970-86. PubMed ID: 20156566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invited article: the Alzheimer disease-frontotemporal lobar degeneration spectrum.
    van der Zee J; Sleegers K; Van Broeckhoven C
    Neurology; 2008 Oct; 71(15):1191-7. PubMed ID: 18838666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.
    Nagao M; Sugawara Y; Ikeda M; Fukuhara R; Hokoishi K; Murase K; Mochizuki T; Miki H; Kikuchi T
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):162-8. PubMed ID: 15129697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontotemporal dementia progresses to death faster than Alzheimer disease.
    Roberson ED; Hesse JH; Rose KD; Slama H; Johnson JK; Yaffe K; Forman MS; Miller CA; Trojanowski JQ; Kramer JH; Miller BL
    Neurology; 2005 Sep; 65(5):719-25. PubMed ID: 16157905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and activities of daily living inventories in the diagnosis of frontotemporal lobar degeneration and Alzheimer's disease.
    Bahia VS; da Silva MM; Viana R; Smid J; Damin AE; Radanovic M; Nitrini R
    Dement Neuropsychol; 2008; 2(2):108-113. PubMed ID: 29213552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical event-related potentials in Alzheimer's disease and frontotemporal lobar degeneration.
    Chen L; Zhou Y; Liu L; Zhang X; Zhang H; Liu S
    J Neurol Sci; 2015 Dec; 359(1-2):88-93. PubMed ID: 26671093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
    van de Pol LA; Hensel A; van der Flier WM; Visser PJ; Pijnenburg YA; Barkhof F; Gertz HJ; Scheltens P
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):439-42. PubMed ID: 16306153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma leptin levels and free leptin index in women with Alzheimer's disease.
    Baranowska-Bik A; Bik W; Styczynska M; Chodakowska-Zebrowska M; Barcikowska M; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B
    Neuropeptides; 2015 Aug; 52():73-8. PubMed ID: 26070219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered serum levels of adipokines and insulin in probable Alzheimer's disease.
    Khemka VK; Bagchi D; Bandyopadhyay K; Bir A; Chattopadhyay M; Biswas A; Basu D; Chakrabarti S
    J Alzheimers Dis; 2014; 41(2):525-33. PubMed ID: 24625795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease.
    Hoefer M; Allison SC; Schauer GF; Neuhaus JM; Hall J; Dang JN; Weiner MW; Miller BL; Rosen HJ
    Brain; 2008 Jun; 131(Pt 6):1646-57. PubMed ID: 18492729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial symptoms in frontotemporal dementia and semantic dementia compared with Alzheimer's disease.
    Shinagawa S; Ikeda M; Fukuhara R; Tanabe H
    Dement Geriatr Cogn Disord; 2006; 21(2):74-80. PubMed ID: 16340203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontotemporal lobar degeneration: demographic characteristics of 353 patients.
    Johnson JK; Diehl J; Mendez MF; Neuhaus J; Shapira JS; Forman M; Chute DJ; Roberson ED; Pace-Savitsky C; Neumann M; Chow TW; Rosen HJ; Forstl H; Kurz A; Miller BL
    Arch Neurol; 2005 Jun; 62(6):925-30. PubMed ID: 15956163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation.
    Flaherty C; Kraft J; Brothers A; Harrison M; Legro RS; Manni A; Yang C; Simmons Z;
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):74-85. PubMed ID: 27892698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease].
    Poljansky S; Ibach B; Vogel M; Männer P; Marienhagen J; Hajak G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S73-5. PubMed ID: 15570509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.